Tone Deaf: FDA Commissioner Hits the Wrong Note

When Andrew von Eschenbach was coaxed to come over from NCI to lead FDA, he seemed like a perfect choice to right the ship and manage FDA through the final years of the Bush Administration. But, as the hoopla over Avandia shows, the ship is still taking on water. The commissioner’s tone and vision aren’t helping.